Browse our press packs

Researchers have identified a conserved region of the SARS-CoV-2 spike protein that could be targeted to boost human antibody responses against any coronavirus.

High-profile news coverage that eLife papers generated in February 2023, including The Scientist, The ASCO Post and Earth.com.

Plasmodium falciparum, a parasite species highly associated with malaria, can rapidly respond to changes in its host environment by investing into replication or transmission.

A study suggests that fruit flies experience two hunger states – one driven by need and the other by pleasure – which arise from unique neural mechanisms.

Researchers have shown that a fatty acid binding protein is a key target linked to more aggressive disease and poorer survival in multiple myeloma.

Researchers have built a model to predict how local tailoring of pandemic control measures such as lockdowns can halt disease transmission while reducing societal burden.

A subset of individuals with SARS-CoV-2 are three times more likely to spread the virus to other individuals than the average person.

A decade-long analysis reveals potential bottlenecks in the pathway of clinical research into medical practice.

PLATCOV, a platform to assess the effectiveness of drugs against COVID-19, suggests that ivermectin has no significant antiviral activity against SARS-CoV-2.

Just one or two mutations with strong effects, or an accumulation of mutations with small effects, may help the Omicron variant of SARS-CoV-2 dodge the immune system or antibody-based therapies.